AI Science Tracker
EN

A biology-based quality-diversity algorithm for drug repurposing in Alzheimer's disease using automated machine learning.

Affiliation not stated in the reviewed material · 30 Mar 2026 · medicine

Discovery

A biology-based quality-diversity algorithm for drug repurposing in Alzheimer's disease using automated machine learning.

Source check: Source checked. Not independent scientific confirmation.

Finding: A biology-based GNN/AutoML quality-diversity search recovered known drug–gene links and prioritized a drug-repurposing candidate for Alzheimer’s disease. Experimental efficacy was not tested.

Technology: A biology-based graph neural network and AutoML quality-diversity search ranks drug-repurposing hypotheses.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A biology-based graph neural network and AutoML quality-diversity search ranks drug-repurposing hypotheses.
Test and result
Evaluation recovered known drug–gene links and ranked a candidate computationally; experimental efficacy remains unestablished.
Limitation / still unknown
External replication and real-world or clinical benefit were not established by the reviewed study; author affiliation is not stated in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1186/s13040-026-00550-4

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.